In summary, we demonstrated that dapagliflozin ameliorates hepatic steatosis by decreasing the de novo lipogenesis enzyme ACC1, increasing the fatty acid oxidation enzyme ACOX1 and inducing autophagy. This evidence concerns the gene ACACA and Hepatic steatosis.